Regencell Bioscience Holdings Limited (RGC)

RGC Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	2.42	2.96	1.56	6.42	0.06
Short-Term Investments	2.48	5	10	10	-
Cash & Short-Term Investments	4.9	7.96	11.56	16.42	0.06
Cash Growth	-38.49%	-31.16%	-29.56%	27532.00%	-84.65%
Other Current Assets	0.01	0.15	0.06	0.03	0.01
Total Current Assets	4.9	8.11	11.62	16.44	0.07
Net Property, Plant & Equipment	0.76	0.23	0.89	1.46	0.08
Other Long-Term Assets	0.09	0.1	0.11	0.11	0.19
Total Assets	5.76	8.44	12.62	18.02	0.34
Accrued Expenses	0.35	0.13	0.16	0.15	0.57
Short-Term Debt	-	-	-	-	3.68
Current Portion of Leases	0.31	0.06	0.44	0.41	-
Other Current Liabilities	0	0.01	0.01	0.02	0.08
Total Current Liabilities	0.66	0.19	0.61	0.58	4.34
Long-Term Leases	0.23	0.03	0.03	0.36	-
Total Long-Term Liabilities	0.23	0.03	0.03	0.36	-
Total Liabilities	0.9	0.22	0.63	0.94	4.34
Common Stock	0	0	0	0	0
Additional Paid-in Capital	30.12	29.88	29.43	28.51	0
Accumulated Other Comprehensive Income	-0.06	-0.05	-0.09	-	-
Retained Earnings	-25.2	-21.62	-17.32	-11.44	-4
Total Common Shareholders' Equity	4.86	8.22	12.03	17.07	-4
Minority Interest	-	-	-0.04	0.02	-
Shareholders' Equity	4.86	8.22	11.99	17.08	-4
Total Liabilities & Equity	5.76	8.44	12.62	18.02	0.34
Total Debt	0.54	0.09	0.46	0.77	3.68
Net Cash (Debt)	4.35	7.88	11.1	15.65	-3.62
Net Cash Growth	-44.73%	-29.06%	-29.05%	-	-
Net Cash Per Share	0.01	0.02	0.02	0.03	-0.01
Book Value	4.86	8.22	12.03	17.07	-4
Book Value Per Share	0.01	0.02	0.02	0.04	-0.01
Tangible Book Value	4.86	8.22	12.03	17.07	-4
Tangible Book Value Per Share	0.01	0.02	0.02	0.04	-0.01

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q